Position in JNJ
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$483,471,520
+$70,021,016 QoQ
Shares Held
1,977,874
-1.0% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
1.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Korea Investment CORP holds $2,395,402,868 across 10 Drug Manufacturers - General names. JNJ ranks #2 (20.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
711,353 | $654,281,148 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,977,874 | $483,471,520 | |
| 3 | ABBV |
AbbVie Inc.
|
1,267,180 | $275,598,978 | |
| 4 | AZN |
Astrazeneca PLC
|
1,345,126 | $265,285,749 | |
| 5 | MRK |
Merck & Co., Inc.
|
1,897,151 | $228,208,293 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,132,515 | $157,838,615 | |
| 7 | AMGN |
Amgen Inc
|
395,932 | $139,308,674 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,703,989 | $103,346,932 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $483,471,520 | 1,977,874 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $413,450,504 | 1,997,828 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $294,065,365 | 1,585,942 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $280,032,909 | 1,833,276 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $306,901,348 | 1,850,587 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $262,974,260 | 1,818,381 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $305,206,301 | 1,883,292 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $257,820,247 | 1,763,959 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $286,531,287 | 1,811,311 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $293,389,850 | 1,871,825 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $296,472,305 | 1,903,514 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $335,487,522 | 2,026,870 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $337,130,580 | 2,175,036 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $374,320,290 | 2,118,994 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $405,326,218 | 2,481,184 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $407,311,960 | 2,294,586 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $379,239,589 | 2,139,816 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $325,768,772 | 1,904,301 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $249,965,824 | 1,547,776 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $269,084,339 | 1,633,388 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $258,076,339 | 1,570,285 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $219,803,990 | 1,396,645 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $272,971,033 | 1,833,497 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $277,610,088 | 1,974,046 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $274,015,279 | 2,089,646 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||